Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI)

NCT02819479 is registered in ClinicalTrials.gov with Norton Healthcare as lead sponsor.

NCT NCT02819479
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02819479 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI)
Lead sponsor
Norton Healthcare
Phase
Phase 2
Overall status
Completed
Start date
November 23, 2016
Completion date
June 6, 2019
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

radiation necrosis